In "Drug prices: So much for restraint" (News: Analysis & Commentary, Mar. 4), the 1.7% rise in drug prices last year was measured at the producer and wholesaler level, not the consumer level.

Before it's here, it's on the Bloomberg Terminal. LEARN MORE